FOSUN HEALTH Logo

Hepatolithiasis & Bile Duct Stones Diagnosis

catalogue

Hepatolithiasis & Bile Duct Stones Diagnosis

Hepatolithiasis & Bile Duct Stones Diagnosis

Diagnosis of bile duct stones runs in a fixed sequence, and the order is not bureaucratic — each step decides whether the next is needed and what it should be. Blood tests say whether bile is obstructed and whether infection is in play. Ultrasound gives the first picture. MRCP maps every duct, stone and stricture before anything is treated, and it is the single most important examination in this disease. ERCP comes last, when it is a treatment rather than a look. Where stones have lived inside the liver for years, one more question is asked: what has the disease done to the liver itself?

Blood tests: the obstructive pattern

The first blood results say more about the ducts than any single scan:

  • Bilirubin rising — the pigment backing up — together with alkaline phosphatase and GGT rising, the cholestatic enzymes, is the signature of obstruction.
  • White cell count and CRP — the inflammation line; raised values with fever point to cholangitis.
  • Blood cultures when cholangitis is suspected, to identify the bacteria driving it.
  • Pancreas enzymes (amylase, lipase), because a stone at the lower end of the duct can inflame the pancreas.
  • Clotting and liver-synthesis tests — how well the liver behind the blockage is still working.

Ultrasound: the first image

Ultrasound is almost always the first scan, and it earns its place:

  • It shows dilated ducts — the stretching that happens above a block — often before the stone itself is seen.
  • Stones in the main duct and in the gallbladder are usually visible; small intrahepatic stones can be missed, which is why a clear ultrasound does not end the workup when suspicion remains.
  • It is fast, safe and repeatable — the right tool for the first hour of an attack.
  • What it cannot do: see through bowel gas to the lower duct, or map the duct tree in enough detail to plan treatment. That detail work belongs to MRCP.

MRCP: the map the plan is written from

MRCP is an MRI scan tuned to show bile and pancreatic ducts, using no needles and no intervention. In this disease it is the pivotal examination:

  • Every duct, every stone, every stricture — the whole tree, including the branches inside the liver that ultrasound can miss.
  • The state of the liver around the diseased ducts — segments that have thinned, scarred or stopped contributing.
  • The basis of the plan: how many sessions endoscopy will need, whether a stricture must be treated alongside the stone, and whether part of the disease is surgical rather than endoscopic at all.
  • Why it comes before treatment, not during it: clearing a duct tree nobody has imaged is how stones get left behind and strictures get missed.

CT: what it adds

CT does not replace MRCP, and it is not routine for every stone. It earns its place in defined situations:

  • Large stone loads, where the volume of disease matters to the choice between endoscopy and surgery.
  • Liver change: segment atrophy, scarring, abscess — the complications of years of disease, seen more crisply than MRI gives them.
  • The acute abdomen: when an attack is severe and the differential is wider, CT sorts the complications faster.
  • Stones MRCP under-calls: some cholesterol-rich stones are hard to see on MRI and obvious on CT — the two scans correct each other.

ERCP: examination and treatment in one

ERCP passes a side-viewing endoscope to the mouth of the bile duct, and it is unique in this disease because it can treat while it examines:

  • As treatment: cutting the muscular gate at the mouth of the duct (sphincterotomy), pulling stones out with balloons and baskets, and crushing stones too large to pull.
  • As drainage: leaving a temporary internal stent or a nose-drain when a duct must be decompressed during infection.
  • As diagnosis: only when something remains unexplained after MRCP — or when treatment is expected at the same sitting anyway.
  • The order matters: during cholangitis, the first ERCP is for drainage; stones are cleared at a second sitting once the fever has settled, when it is also safer.

Assessing the liver before any decision

Where intrahepatic disease has run for years, one more layer of assessment decides what treatment is even on the table:

  • Segment-by-segment review of the MRCP and CT: which segments hold stones, which ducts drain them, and which segments have scarred, thinned or stopped working.
  • Liver reserve tests — blood measures of liver function — because the segments that remain have to carry the whole load, and removing diseased tissue is only sound when the remainder is healthy.
  • The gallbladder — whether it holds stones and belongs to the same disease.
  • The long-term risk line: ducts that have been inflamed for decades carry a raised risk of bile duct cancer, which is a reason long-standing disease is mapped and treated rather than indefinitely observed.

What your assessment visit looks like

Assessment is organised so that the plan, not the scan, is what you leave with:

  • Before you travel: send the images themselves — MRCP especially — liver test results and the attack history; a written opinion follows within about 48 hours of complete records arriving.
  • On arrival: a focused review of the duct map, blood tests to update the picture, and any missing scan arranged in a day or two.
  • The plan you take home: which stones, which route — endoscopic, percutaneous, surgical or a combination — how many stages, how long the stay, and what follow-up looks like afterwards.

Frequently Asked Questions

Is MRCP uncomfortable or risky?

No. MRCP is a standard MRI scan adapted to show the ducts: you lie in the scanner, there are no needles in the ducts and no instruments passed, and the scan takes roughly half an hour. It carries none of the risks that come with intervention — no pancreatitis, no bleeding, no perforation — which is exactly why it is done first, to plan any intervention that follows with the map already in hand.

Why not just do ERCP and look directly?

Because ERCP is an intervention with real risks, and it is at its best when it treats a problem that has already been mapped. Going straight to ERCP without imaging risks treating the stone you can reach while missing a stricture, a second stone, or a segment of liver disease that needs surgery — and it exposes every patient to the procedure's risks even when the disease turns out to need something else. The sequence — blood tests, ultrasound, MRCP, then ERCP when it can treat — is what keeps ERCP both safe and effective.

What if my scans show a stricture as well as stones?

Then the stricture is part of the disease and is treated as such. A narrowed duct keeps bile stagnant, which is why stones formed there in the first place and why they return if only the stones are removed. Treatment therefore pairs stone clearance with opening or bypassing the narrowing — by endoscopy with balloons and stents, or surgically with a drainage reconstruction — planned from the MRCP rather than discovered during it.

Do I need new scans if I already have images?

Usually no, provided the images themselves arrive — not the reports alone. MRCP from recent months is typically enough to write the plan; very old images are repeated because duct disease changes. What genuinely speeds the assessment is completeness: the MRCP or CT images, liver test results, the attack history, and any operative notes from earlier treatment. Gaps in the record delay the plan more than any scan does.

Send the MRCP images, not just the report

The duct map is what the plan is written from, and the images themselves are what we need — MRCP especially, plus liver tests and the attack history. Send them and ask the specific question; a written opinion follows within about 48 hours of complete records arriving.

Want to see the whole process first? Your full medical journey, step by step →

Book an Appointment Request a Video Consultation

Follow Fosun Health

Apply for an Appointment

Do you have test results*